Shopping Cart
- Remove All
- Your shopping cart is currently empty
H2L5186303 is an LPA2 antagonist and can be used in studies about asthma treatment.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | 28 € | In Stock | |
5 mg | 55 € | In Stock | |
10 mg | 100 € | In Stock | |
25 mg | 226 € | In Stock | |
50 mg | 335 € | In Stock | |
100 mg | 470 € | In Stock | |
500 mg | 937 € | In Stock | |
1 mL x 10 mM (in DMSO) | 65 € | In Stock |
Description | H2L5186303 is an LPA2 antagonist and can be used in studies about asthma treatment. |
Targets&IC50 | LPA2 receptor:9 nM (IC50) |
In vitro | The high cell invasion activity of HT1080-M6 cells is significantly suppressed by H2L5186303[1]. |
In vivo | H2L5186303 shows strong suppressive efficacy when administered before OVA sensitization and challenge, such as suppression of airway hyper responsiveness, inflammatory cytokine levels, mucin production, and eosinophil numbers[2]. |
Alias | ZINC33388081 |
Molecular Weight | 488.45 |
Formula | C26H20N2O8 |
Cas No. | 139262-76-3 |
Smiles | OC(=O)\C=C/C(=O)Nc1ccc(Oc2cccc(Oc3ccc(NC(=O)\C=C/C(O)=O)cc3)c2)cc1 |
Relative Density. | no data available |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 200 mg/mL (409.5 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.